Abstract
Biochemical markers of bone turnover have a number of potential uses in osteoporosis, including the prediction of the rate of postmenopausal bone loss, the response to therapy, and the therapeutic monitoring. The authors discuss recent advancements and the development of assays for pyridinium cross-links of collagen, telopeptides of type 1 collagen, and bone-specific alkaline phosphatase.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Physical Medicine and Rehabilitation Clinics of North America
Paper Title
Journal
Date
